Cancer Prevention Web-Based Activity

• いつ講座や課題にアクセスできるようになりますか？

  講義と課題へのアクセスは、登録のタイプによって異なります。聴講モードでコースを受講すると、ほとんどのコース教材を無料で見ることができます。採点された課題にアクセスして修了証を取得するには、聴講中または聴講後に、修了証エクスペリエンスを購入する必要があります。聴講オプションが表示されない場合：

  • コースは聴講オプションを提供していない可能性があります。代わりに無料トライアルをお試しいただくか、学資援助を申請することができます。
  • コースは、聴講オプションを提供せずに「修了証なしフルコース」オプションを提供する場合があります。このオプションでは、すべてのコース教材が表示され、必須の評価を提出して、最終成績を取得することができます。この場合、修了証エクスペリエンスは購入できません。

• 修了証を購入すると何を行えるようになりますか？

  修了証を購入する際、コースのすべての教材（採点課題を含む）にアクセスできます。コースを完了すると、電子修了証が成果のページに追加されます。そこから修了証を印刷したり、LinkedInのプロフィールに追加したりできます。コースの内容の閲覧のみを希望する場合は、無料でコースを聴講できます。

• Is financial aid available?

  はい。受講料の支払いが難しい受講生に、Coursera（コーセラ）は学資援助を提供しています。左側の［登録］ボタンの下にある［学資援助］のリンクをクリックして申請してください。申請書の入力を促すメッセージが表示され、承認されると通知が届きます。詳細。

• Who are the Speakers and Planning Committee?

  DISCLOSURES

  Thomas S Uldrick, MD, MS has disclosed relevant financial relationship as research support from Roche, Celgene and Merck through CRADAs or CTAs to the NCI or Fred Hutchinson Cancer Research Center and also a patent with Celgene, but no anticipated royalties.

  All other speakers and planning committee members have disclosed no financial relationship or interest with any proprietary entity producing healthcare goods or services.

• Is this activity accredited for continuing medical and nursing education?

  ACCREDITATION AND DESIGNATION STATEMENT

  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Virginia School of Medicine and Next Generation Choices Foundation. The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

  The University of Virginia School of Medicine designates this enduring activity for a maximum of 4AMA PRA Category 1 Credits.TM   Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  The University of Virginia School of Medicine and/or The University of Virginia School of Nursing Continuing Education, as accredited provider(s),  awards 4hours of participation(consistent with the  designated number of AMA PRA Category 1 Credit(s)TM  or ANCC contact hours) to participants who successfully completes this educational activity. The University of Virginia School of Medicine and/or The University of Virginia School of Nursing Continuing Education maintains a record of participation for six (6) years.

  The University of Virginia School of Nursing Continuing Education (SONCE) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

  The University of Virginia SONCE awards 4 contact hours for nurses who participate in this educational activity and complete the post activity evaluation.

  DISCLOSURE OF FACULTY FINANCIAL AFFILIATIONS

  The University of Virginia School of Medicine, as an ACCME accredited provider, and The University of Virginia School of Nursing Continuing Education as an ANCC accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support and with the American Nurses Credentialing Center (ANCC) Content Integrity Standards, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing education activities under our auspices.

  The University of Virginia School of Medicine and School of Nursing require that all CE activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.

  All faculty presenters participating in an accredited CE activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.).  The University of Virginia School of Medicine and School of Nursing will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant.  Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine or the University of Virginia School of Nursing Continuing Education, Charlottesville, Virginia.

  The faculty, staff and planning committee of the University of Virginia Office of Continuing Medical Education and the University of Virginia School of Nursing Continuing Education have no financial affiliations to disclose.

  DISCLOSURE OF DISCUSSION OF NON-FDA APPROVED USES FOR PHARMACEUTICAL PRODUCTS AND/OR MEDICAL DEVICES

  The University of Virginia School of Medicine and the University of Virginia School of Nursing Continuing Education requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products.  It is recommended that each clinician fully review all the available data on new products or procedures prior to clinical use.

• Do any Speakers or Planning Committee Members disclose a Conflict of Interest?

  DISCLOSURES

  Thomas S Uldrick, MD, MS has disclosed relevant financial relationship as research support from Roche, Celgene and Merck through CRADAs or CTAs to the NCI or Fred Hutchinson Cancer Research Center and also a patent with Celgene, but no anticipated royalties.

  All other speakers and planning committee members have disclosed no financial relationship or interest with any proprietary entity producing healthcare goods or services.

• When does this enduring material expire?

  Dates of original release: April 20, 2020

  Termination or expiration date: April 19, 2023

さらに質問がある場合は、受講者向けヘルプセンターにアクセスしてください。